Literature DB >> 28275332

HCV RNA Testing of Plasma Samples from Cornea Donors: Suitability of Plasma Samples Stored at 4 °C for up to 8 Days.

Annemarie Berger1, Sabine Salla2, Oliver T Keppler3, Holger F Rabenau1.   

Abstract

BACKGROUND: The HCV RNA testing of potential cornea donors frequently relies on blood samples stored pre mortem. The recommended storage time of maximum 72 h frequently excludes a significant fraction of donors.
METHODS: The influence of storage time of EDTA plasma samples at 4 °C on the viral load measured with the Roche HCV Quantitative Test vs. 2.0 was evaluated for 43 samples from HCV-positive individuals.
RESULTS: The mean reduction of the viral load after 4 °C storage for 6-8 days was 0.46 log10 IU/ml (range +0.17 to -1.66 log10 IU/ml). After 1-3 days a mean loss of 0.19 log10 IU/ml (range +0.30 to -1.41 log10 IU/ml) and after 3-5 days of 0.32 log10 IU/ml (range +0.36 to -1.81 log10 IU/ml) was observed. In 23.3% of samples, a viral load reduction ≥ 1 log10 IU/ml (1.0-1.81 log10 IU/ml) was found after prolonged storage (5-8 days). In none of the samples did the HCV load fall below the detection limit.
CONCLUSION: Plasma storage for up to 8 days can quantitatively reduce the HCV RNA load, yet has no influence on the reliability of a qualitative HCV RNA detection by this ultrasensitive test to determine the HCV status of serologically negative cornea donors.

Entities:  

Keywords:  Cornea donor testing; HCV-PCR; Prolonged sample storage at 4 °C

Year:  2016        PMID: 28275332      PMCID: PMC5318926          DOI: 10.1159/000449207

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  18 in total

1.  Biological qualification of blood units: considerations about the effects of sample's handling and storage on stability of nucleic acids.

Authors:  G Gessoni; P Barin; S Valverde; A Giacomini; C Di Natale; E Orlandini; N Arreghini; G De Fusco; A Frigato; M Fezzi; F Antico; G Marchiori
Journal:  Transfus Apher Sci       Date:  2004-06       Impact factor: 1.764

2.  Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT.

Authors:  T J Schulze; C Weiss; J Luhm; C Brockmann; S Görg; H Hennig
Journal:  Transfus Med       Date:  2010-11-23       Impact factor: 2.019

3.  Viral HCV RNA reactivity of corneal cells in plasma HCV nucleic acid-positive eye donors.

Authors:  Ellen Heck; Alison Dingrando; Chris Proctor; H Dwight Cavanagh
Journal:  Cornea       Date:  2013-04       Impact factor: 2.651

4.  Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors.

Authors:  I Wilkemeyer; A Pruss; U Kalus; J Schroeter
Journal:  Cell Tissue Bank       Date:  2012-07-17       Impact factor: 1.522

5.  The effect of storage at different temperatures on the stability of Hepatitis C virus RNA in plasma samples.

Authors:  Marta José; Sònia Curtu; Rodrigo Gajardo; Juan I Jorquera
Journal:  Biologicals       Date:  2003-03       Impact factor: 1.856

6.  Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation.

Authors:  A Heim; D Wagner; T Rothämel; U Hartmann; J Flik; W Verhagen
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

7.  Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.

Authors:  C Micha Nübling; Gabriele Unger; Michael Chudy; Steven Raia; Johannes Löwer
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

8.  The stability of hepatitis C virus RNA after storage at +4 degrees C.

Authors:  G Gessoni; P Barin; A Frigato; M Fezzi; G de Fusco; N Arreghini; P Galli; G Marchiori
Journal:  J Viral Hepat       Date:  2000-07       Impact factor: 3.728

9.  Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor.

Authors:  Barna D Tugwell; Priti R Patel; Ian T Williams; Katrina Hedberg; Feng Chai; Omana V Nainan; Ann R Thomas; Judith E Woll; Beth P Bell; Paul R Cieslak
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

10.  The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes.

Authors:  Kirsty M Allison; Helen M Faddy; Angelo Margaritis; Susan Ismay; Denese C Marks
Journal:  Transfusion       Date:  2015-10-12       Impact factor: 3.157

View more
  2 in total

1.  How safe is safe, and where are we in the journey toward safest of safe?

Authors:  Lalit Dar; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

2.  903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNA.

Authors:  Ricardo Madrid; Verónica Briz; Sonia Arca-Lafuente; Cristina Casanueva-Benítez; Celia Crespo-Bermejo; Violeta Lara-Aguilar; Luz Martín-Carbonero; Ignacio de Los Santos
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.